Related Experiment Videos

Diabetes mellitus and coronary revascularization procedures

Kyriakos Anastasiadis1, Georgios Moschos

  • 1Kyanous Stavros Hospital, Thessaloniki, Greece. anastasiadisk@hotmail.com

International Journal of Cardiology
|December 13, 2006
PubMed

Insights

Revascularization strategies for coronary artery disease (CAD) in diabetic patients are debated. While drug-eluting stents improve percutaneous coronary intervention outcomes, coronary artery bypass grafting may be superior for multivessel disease.

Area of Science:

  • Cardiology
  • Diabetology
  • Vascular Surgery

Background:

  • Coronary artery disease (CAD) management in diabetic patients presents unique challenges.
  • Percutaneous coronary intervention (PCI) outcomes are less favorable in diabetics, despite advances like drug-eluting stents (DES).
  • Coronary artery bypass grafting (CABG) outcomes can also be worse in diabetic populations, yet may offer superior revascularization in complex cases.

Purpose of the Study:

  • To review the controversial revascularization strategies for coronary artery disease in diabetic patients.
  • To compare the outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in this specific patient group.

Main Methods:

  • Review of existing literature and outcomes data for diabetic patients undergoing revascularization.
  • Analysis of results from ongoing randomized trials (FREEDOM, CARDia, SYNTAX) comparing PCI with DES and CABG.

Main Results:

  • Drug-eluting stents have improved outcomes for PCI in diabetic patients.
  • Coronary artery bypass grafting appears superior to angioplasty for diabetic patients with multivessel coronary artery disease.
  • Outcomes for both procedures can be worse in diabetic populations compared to non-diabetics.

Conclusions:

  • The optimal revascularization strategy for diabetic patients with coronary artery disease is still under investigation.
  • Randomized trials are crucial to define the definitive role of PCI and CABG in this population.
  • Further research is needed to optimize treatment and improve long-term outcomes for diabetic patients with CAD.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...